Pharmacogenomics and dermatological therapeutics.

Pharmacogenomics and dermatological therapeutics. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Pharmacogenomics and dermatological therapeutics. Abstract Text:

Pharmacogenomics and dermatological therapeutics. Publishing Authors By Initials

For similar genetic phenomena: variation (genetics): polymorphism, genetic research abstracts see: genetic phenomena: variation (genetics): polymorphism, genetic research

PUBMED ID PMID:

MEDLINE DATE:

Pharmacogenomics and dermatological therapeutics. Journal Published:

PUBLICATION TYPE: Review

Journal: Archives of dermatology

VOLUME: 137

Page Numbers: 1512-4

Journal Abbreviation: Arch Dermatol

ISSN: 0003-987X

DAY: 17

MONTH: Nov

YEAR: 2001

Pharmacogenomics and dermatological therapeutics. Information

Number of References: 12

LANGUAGE: eng

NlmUniqueID: 372433

Pharmacogenomics and dermatological therapeutics. Keywords Mesh Terms:

KEYWORDS: Polymorphism, Genetic

MESH TERMS: genetics

Chemical & Substance for Abstract: Pharmacogenomics and dermatological therapeutics. Information

Substance Name: Anticonvulsants

Registry Number: 0

Grant and Affiliation Information for Pharmacogenomics and dermatological therapeutics.

AFFILIATION: Department of Dermatology, University of Maryland School of Medicine, 405 W Redwood St, Sixth Floor, Baltimore, MD 21201, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Arch Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Pharmacogenomics and dermatological therapeutics Related Publications

• An antibody-complement system in normal serum lethal to mouse tumor cells.
• Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use.
• Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome.
• Brief interpersonal psychotherapy for depressed mothers whose children are receiving psychiatric treatment.
• Bullae on the legs of an elderly man. Mycosis fungoides bullosa.
• Chemical alteration of polysaccharide from Serratia marcescens; tumor-necrotizing polysaccharide tagged with radioactive iodine.
• Clinical presentation and treatment outcome of African Americans with complicated grief.
• Complicated grief: a case series using escitalopram.
• Damage induced in sarcoma 37 with chemical agents. IV. Derivatives of colchicineamide.
• Damage induced in sarcoma 37 with chemical agents. V. Derivatives of colchicine and isocolchicine.
• Damage induced in sarcoma 37 with chemical agents. VI. Biphenyl, fluorene, phenanthrene, and tropolone derivatives.
• Damage induced in sarcoma 37 with chemical agents. VII. Diphenylpropylamines, diphenylpropylenediamines, diphenylalkanes, and related compounds.
• Development of nursing communication systems (patient-nurse call systems).
• Do-not-resuscitate orders in a county hospital.
• Effect of various drugs on the tumor-necrotizing activity of several chemical agents in mice.
• Is a drug alone sufficient to cause the drug hypersensitivity syndrome?
• Multiphoton fabrication of chemically responsive protein hydrogels for microactuation.
• National appraisal of dermatology residency training: a Canadian study.
• Negative results with diphenylethylamines in producing damage in sarcoma 37.
• Odontogenic keratocysts: clinical features.
• Odontogenic keratocysts: natural history and immunohistochemistry.
• Peripheral edema due to nifedipine-itraconazole interaction: a case report.
• Pharmacogenomics and dermatological therapeutics.
• Pursuit eye movement dysfunction in obsessive-compulsive disorder.
• Review: Oral antifungal therapy has low risk for adverse events in superficial dermatophytosis and onychomycosis.
• Seasonal prevalence of vitamin D deficiency in institutionalized older adults.
• Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature.
• The drug hypersensitivity syndrome: what is the pathogenesis?
• The failure of torcetrapib: is there a case for independent preclinical and clinical testing? - correspondence.
• The genus Venturia and a proposed lectotype.